Determination of gene copy number status in tert and terc among chronic myeloid leukaemia patients resist ant and responsive to imatinib mesylate treatment

The frontline treatment of chronic phase (CP) chronic myeloid leukaemia (CML) patients is the use of Imatinib Mesylate (IM). A remarkable CP CML (1/3) patients failed to achieve any degree of good response towards IM treatment. Cancer cells express a higher telomerase activity compared to normal cel...

詳細記述

書誌詳細

第一著者:	Asrari, Zaidatul Shakila Mohamad
フォーマット:	学位論文
言語:	英語
出版事項:	2014
主題:	R735-854 Medical education. Medical schools. Research RB Pathology RC Internal medicine
オンライン･アクセス:	http://eprints.usm.my/62588/